Evidence map›Paper›PMID 21309953›Full record

ArticleAddiction biology2012

Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol-dependent rats.

Scott Edwards, Miguel Guerrero, Ola M Ghoneim, Edward Roberts, George F Koob

Abstract read
In one paragraph

Article in Addiction biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 101 citations in OpenAlex.

  1. Oxytocin Reduces Alcohol Cue-Reactivity in Alcohol-Dependent Rats and Humans.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  2. A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. The Relationship Between Oxytocin and Alcohol Dependence.Current topics in behavioral neurosciences · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Activation of hypothalamic oxytocin neurons reduces binge-like alcohol drinking through signaling at central oxytocin receptors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  18. Article
  19. Vasopressin V1B Receptor Antagonists as Potential Antidepressants.The international journal of neuropsychopharmacology · 2021
    Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Scott EdwardsCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA. edwards@scripps.edu
Miguel Guerrero
Ola M Ghoneim
Edward Roberts
George F Koob
Scripps Research Institute · US

Funding

Viral Vector CoreP60AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI AMANDA J ROBERTS · 2003 to 2026
$46.3M
Neurpsychopharmacology-Multidisciplinary TrainingT32AA007456 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARISA ROBERTO · 1985 to 2026
$13.4M
Medication Development for Protracted Abstinence in AlcoholismR01AA012602 · NIAAA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MASON, BARBARA J · 1999 to 2016
$10.5M
NEUROPHARMACOLOGY OF ETHANOL REINFORCEMENTR01AA008459 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI GEORGE, OLIVIER · 1990 to 2013
$4.2M
NEUROPHARMACOLOGY OF ETHANOL REINFORCEMENTR37AA008459 · NIAAA · SCRIPPS RESEARCH INSTITUTE · PI KOOB, GEORGE F · 1993 to 2002
$788k
Role of Central Vasopressin/ERK Signaling in Ethanol DependenceF32AA018250 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI EDWARDS, SCOTT · 2009 to 2011
$113k
NIAAA NIH HHS AA008459NIAAA NIH HHS AA018250NIAAA NIH HHS AA12602NIAAA NIH HHS F32 AA018250NIAAA NIH HHS P60 AA006420NIAAA NIH HHS R01 AA008459NIAAA NIH HHS R01 AA012602NIAAA NIH HHS R37 AA008459NIAAA NIH HHS T32 AA007456
6 · The paper itself

Abstract

Alcoholism is a devastating condition that represents a progression from initial alcohol use to dependence. Although most individuals are capable of consuming alcohol in a limited fashion, the development of alcohol dependence in a subset of individuals is often associated with negative emotional states (including anxiety and depression). Since the alleviation of this negative motivational state via excessive alcohol consumption often becomes a central goal of alcoholics, the transition from initial use to dependence is postulated to be associated with a transition from positive to negative reinforcement mechanisms. Vasopressin is a neuropeptide known to potentiate the effects of CRF on the HPA axis, and emerging evidence also suggests a role for centrally located vasopressin acting on V(1b) receptors in the regulation of stress- and anxiety-like behaviors in rodents. The present study determined state-dependent alterations in vasopressin/V(1b) R signaling in an animal model of ethanol dependence. The V(1b) R antagonist SSR149415 dose-dependently reduced excessive levels of ethanol self-administration observed in dependent animals without affecting the limited levels of ethanol drinking in non-dependent animals. Ethanol self-administration reduced V(1b) receptor levels in the basolateral amygdala of non-dependent animals, a neuroadaptation that could theoretically facilitate the positive reinforcing effects of alcohol. In contrast, V(1b) R levels were seemingly restored in ethanol-dependent rats, a switch that may in part underlie a transition from positive to negative reinforcement mechanisms with dependence. Together, our data suggest a key role for vasopressin/V(1b) R signaling in the transition to ethanol dependence.

Indexed as

Alcohol DrinkingAlcoholismAntidiuretic Hormone Receptor AntagonistsAmygdalaAnalysis of VarianceAnimalsBlotting, WesternCentral Nervous System DepressantsDisease Models, AnimalDose-Response Relationship, DrugEthanolMaleRatsRats, WistarReinforcement, PsychologySelf AdministrationAntidiuretic Hormone Receptor AntagonistsCentral Nervous System DepressantsEthanol

Identifiers

PMID21309953
PMCPMC3178679
OpenAlexW2142371956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.